Suppr超能文献

[bag-1、bcl-2在非小细胞肺癌中的表达及意义与多药耐药的相关性]

[Expression and Significance of bag-1, bcl-2 in Non-small Cell Lung Cancer and the Correlation with Multi-drug Resistance.].

作者信息

Ma Jiabao, Zhu Wen, Zhou Qinghua

机构信息

Department of Radiation Oncology, Sichuan Province Cancer Hospital, Chengdu 610041, China.

出版信息

Zhongguo Fei Ai Za Zhi. 2009 Oct 20;12(10):1089-94. doi: 10.3779/j.issn.1009-3419.2009.10.07.

Abstract

BACKGROUND

bag-1, bcl-2 and bax are all apoptosis-related proteins. They play a role in the diagnosis, progress, metastasis and prognosis of tumor. The aim of the study was to investigate the expression of bag-1, bcl-2 and bax in non-small cell lung cancer, and to study the relationship between their expression levels and the clinical pathological characteristics, furthermore, to evaluate their correlation with multi-drug resistance.

METHODS

The expressions of bag-1, bcl-2 and bax in 140 non-small cell lung cancer tissues (40 of 140 were processed neoadjuvant chemotherapy) and 15 lung benign lesion tissues were examined with SP immuno-histochemical stain.

RESULTS

The positive expression rates of bag-1 and bcl-2 protein in non-small cell lung cancer were significantly higher than those in pulmonary benign lesion tissues (P<0.05), but the positive expression rate of bax in non-small cell lung cancer was significantly lower than that in pulmonary benign lesion tissues (P<0.05). The expressions of bag-1, bcl-2 and bax protein were not related to the age and sex of patients, histological classification, P-TNM stage and lymph node involvement of the cancer (P>0.05), but bag-1 was related to the differentiation degree of the tumor. The lower the differentiation was, the higher the levels of expression of bag-1 were. bcl-2 protein expression was highly positive correlated with the bag-1 protein expression in non-small cell lung cancer (r =0.371, P<0.01), and bcl-2 protein was highly negative correlated with bax protein expression (r=-0.225, P<0.01). The positive expression rates of bag-1 and bcl-2 showed increasing trends from the patients without neoadjuvant therapy to those with neoadjuvant therapy, but the difference had no statistic significance (P>0.05).

CONCLUSIONS

The high expression of bag-1, bcl-2 protein and the low expression of bax protein exist in nonsmall cell lung cancer. The expression level of bag-1 protein is closely related to the differentiation degree of non-small cell lung cancer. A highly positive correlation exists between bag-1 and bcl-2 expression, and a highly negative correlation is observed between bcl-2 and bax expression. The study doesn't provide the evidence that there is a close correlation between the expression levels of bag-1, bcl-2, bax and the multi-drug resistance in non-small cell lung cancer.

摘要

背景

Bag-1、Bcl-2和Bax均为凋亡相关蛋白。它们在肿瘤的诊断、进展、转移及预后中发挥作用。本研究旨在探讨Bag-1、Bcl-2和Bax在非小细胞肺癌中的表达情况,研究其表达水平与临床病理特征之间的关系,并评估它们与多药耐药性的相关性。

方法

采用SP免疫组织化学染色法检测140例非小细胞肺癌组织(140例中有40例接受了新辅助化疗)及15例肺良性病变组织中Bag-1、Bcl-2和Bax的表达。

结果

非小细胞肺癌中Bag-1和Bcl-2蛋白的阳性表达率显著高于肺良性病变组织(P<0.05),但非小细胞肺癌中Bax的阳性表达率显著低于肺良性病变组织(P<0.05)。Bag-1、Bcl-2和Bax蛋白的表达与患者的年龄、性别、组织学分类、肿瘤的P-TNM分期及淋巴结受累情况无关(P>0.05),但Bag-1与肿瘤的分化程度有关。分化程度越低,Bag-1的表达水平越高。非小细胞肺癌中Bcl-2蛋白表达与Bag-1蛋白表达呈高度正相关(r =0.371,P<0.01),且Bcl-蛋白与Bax蛋白表达呈高度负相关(r=-0.225,P<0.01)。从未接受新辅助治疗的患者到接受新辅助治疗的患者,Bag-1和Bcl-2的阳性表达率呈上升趋势,但差异无统计学意义(P>0.05)。

结论

非小细胞肺癌中存在Bag-1、Bcl-2蛋白的高表达及Bax蛋白的低表达。Bag-1蛋白的表达水平与非小细胞肺癌的分化程度密切相关。Bag-1与Bcl-2表达之间存在高度正相关,Bcl-2与Bax表达之间存在高度负相关。本研究未提供证据表明Bag-1、Bcl-2、Bax的表达水平与非小细胞肺癌的多药耐药性密切相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验